112 related articles for article (PubMed ID: 9598826)
1. Binding of human urokinase-type plasminogen activator to its receptor: residues involved in species specificity and binding.
Quax PH; Grimbergen JM; Lansink M; Bakker AH; Blatter MC; Belin D; van Hinsbergh VW; Verheijen JH
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):693-701. PubMed ID: 9598826
[TBL] [Abstract][Full Text] [Related]
2. A composite role of vitronectin and urokinase in the modulation of cell morphology upon expression of the urokinase receptor.
Hillig T; Engelholm LH; Ingvarsen S; Madsen DH; Gårdsvoll H; Larsen JK; Ploug M; Danø K; Kjøller L; Behrendt N
J Biol Chem; 2008 May; 283(22):15217-23. PubMed ID: 18362146
[TBL] [Abstract][Full Text] [Related]
3. Urokinase and its receptors in chronic kidney disease.
Zhang G; Eddy AA
Front Biosci; 2008 May; 13():5462-78. PubMed ID: 18508599
[TBL] [Abstract][Full Text] [Related]
4. Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation.
Bernstein AM; Twining SS; Warejcka DJ; Tall E; Masur SK
Mol Biol Cell; 2007 Jul; 18(7):2716-27. PubMed ID: 17507651
[TBL] [Abstract][Full Text] [Related]
5. Post-transcriptional regulation of urokinase-type plasminogen activator receptor expression in lipopolysaccharide-induced acute lung injury.
Bhandary YP; Velusamy T; Shetty P; Shetty RS; Idell S; Cines DB; Jain D; Bdeir K; Abraham E; Tsuruta Y; Shetty S
Am J Respir Crit Care Med; 2009 Feb; 179(4):288-98. PubMed ID: 19029002
[TBL] [Abstract][Full Text] [Related]
6. Urokinase plasminogen activator inhibits HIV virion release from macrophage-differentiated chronically infected cells via activation of RhoA and PKCε.
Graziano F; Elia C; Laudanna C; Poli G; Alfano M
PLoS One; 2011; 6(8):e23674. PubMed ID: 21858203
[TBL] [Abstract][Full Text] [Related]
7. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R.
Resnati M; Pallavicini I; Wang JM; Oppenheim J; Serhan CN; Romano M; Blasi F
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1359-64. PubMed ID: 11818541
[TBL] [Abstract][Full Text] [Related]
8. Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.
Mahmood N; Mihalcioiu C; Rabbani SA
Front Oncol; 2018; 8():24. PubMed ID: 29484286
[TBL] [Abstract][Full Text] [Related]
9. Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication.
Alfano M; Sidenius N; Panzeri B; Blasi F; Poli G
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8862-7. PubMed ID: 12084931
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells.
Ustach CV; Kim HR
Mol Cell Biol; 2005 Jul; 25(14):6279-88. PubMed ID: 15988036
[TBL] [Abstract][Full Text] [Related]
11. IL4 stimulated macrophages promote axon regeneration after peripheral nerve injury by secreting uPA to stimulate uPAR upregulated in injured axons.
Matsui Y; Kadoya K; Nagano Y; Endo T; Hara M; Matsumae G; Suzuki T; Yamamoto Y; Terkawi MA; Iwasaki N
Cell Mol Life Sci; 2022 May; 79(6):289. PubMed ID: 35536429
[TBL] [Abstract][Full Text] [Related]
12. Decreased fertility in female mice lacking urokinase plasminogen activator.
Laurenzi G; Fedeli V; Canipari R
Reprod Biol; 2024 Mar; 24(1):100840. PubMed ID: 38113659
[TBL] [Abstract][Full Text] [Related]
13. The role of Ly49E receptor expression on murine intraepithelial lymphocytes in intestinal cancer development and progression.
Van Acker A; Louagie E; Filtjens J; Taveirne S; Van Ammel E; Kerre T; Elewaut D; Taghon T; Vandekerckhove B; Plum J; Leclercq G
Cancer Immunol Immunother; 2016 Nov; 65(11):1365-1375. PubMed ID: 27585789
[TBL] [Abstract][Full Text] [Related]
14. Positron emission computed tomography targeting urokinase plasminogen activator receptor (uPAR) in cancer: a systematic review.
Camedda R; Frantellizzi V; Danieli R; De Vincentis G; Filippi L
Expert Rev Anticancer Ther; 2024; 24(3-4):137-145. PubMed ID: 38451196
[TBL] [Abstract][Full Text] [Related]
15. Soluble urokinase plasminogen activator receptor, platelet aggregation, and carotid plaque thickness in diabetes: A cross-sectional analysis.
Rotbain Curovic V; Tavenier J; Ferreira-Divino LF; Poulsen CG; Houlind MB; Pedersen OB; Urbak L; Hansen TW; Sillesen H; Frimodt-Møller M; Hvas AM; Rossing P
J Diabetes Complications; 2024 Jan; 38(1):108654. PubMed ID: 38042098
[No Abstract] [Full Text] [Related]
16. All tangled up: interactions of the fibrinolytic and innate immune systems.
Whyte CS
Front Med (Lausanne); 2023; 10():1212201. PubMed ID: 37332750
[TBL] [Abstract][Full Text] [Related]
17. The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review.
Tucker TA; Idell S
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535429
[TBL] [Abstract][Full Text] [Related]
18. Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction.
Parker AL; White KM; Lavery CA; Custers J; Waddington SN; Baker AH
Gene Ther; 2013 Dec; 20(12):1158-64. PubMed ID: 24005577
[TBL] [Abstract][Full Text] [Related]
19. Stroma targeting nuclear imaging and radiopharmaceuticals.
Shetty D; Jeong JM; Shim H
Int J Mol Imaging; 2012; 2012():817682. PubMed ID: 22685650
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein receptor-related protein 1 regulates collagen 1 expression, proteolysis, and migration in human pleural mesothelial cells.
Tucker TA; Williams L; Koenig K; Kothari H; Komissarov AA; Florova G; Mazar AP; Allen TC; Bdeir K; Mohan Rao LV; Idell S
Am J Respir Cell Mol Biol; 2012 Feb; 46(2):196-206. PubMed ID: 22298529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
